|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
558 a.a.
|
 |
|
|
|
|
|
|
|
430 a.a.
|
 |
|
|
|
|
|
|
|
214 a.a.
|
 |
|
|
|
|
|
|
|
220 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system/DNA
|
 |
|
Title:
|
 |
HIV-1 reverse transcriptase/fragment of fab 28/DNA complex
|
|
Structure:
|
 |
DNA (5'- d( Ap Tp Gp Gp Cp Gp Cp Cp Cp Gp Ap Ap Cp Ap Gp Gp Gp Ap C)-3'). Chain: e. Engineered: yes. DNA (5'- d( Gp Tp Cp Cp Cp Tp Gp Tp Tp Cp Gp Gp Gp Cp Gp Cp Cp A)-3'). Chain: f. Engineered: yes. Subunit of v-1 reverse transcriptase.
|
|
Source:
|
 |
Synthetic: yes. Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: bh10 isolate. Atcc: atcc 1065288. Expressed in: escherichia coli. Expression_system_taxid: 562. Mus musculus. House mouse.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.271
|
R-free:
|
0.352
|
|
|
Authors:
|
 |
J.Ding,E.Arnold
|
Key ref:
|
 |
J.Ding
et al.
(1998).
Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
J Mol Biol,
284,
1095-1111.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Apr-98
|
Release date:
|
14-Oct-98
|
|
|
Supersedes:
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P03366
(POL_HV1B1) -
Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate BH10)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1447 a.a.
558 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P03366
(POL_HV1B1) -
Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate BH10)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1447 a.a.
430 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B:
E.C.2.7.7.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, B:
E.C.2.7.7.49
- RNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains A, B:
E.C.2.7.7.7
- DNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains A, B:
E.C.3.1.-.-
|
|
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
Chains A, B:
E.C.3.1.13.2
- exoribonuclease H.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
|
 |
 |
 |
 |
 |
Enzyme class 7:
|
 |
Chains A, B:
E.C.3.1.26.13
- retroviral ribonuclease H.
|
|
 |
 |
 |
 |
 |
Enzyme class 8:
|
 |
Chains A, B:
E.C.3.4.23.16
- HIV-1 retropepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
284:1095-1111
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
|
|
J.Ding,
K.Das,
Y.Hsiou,
S.G.Sarafianos,
A.D.Clark,
A.Jacobo-Molina,
C.Tantillo,
S.H.Hughes,
E.Arnold.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of human immunodeficiency virus type 1 (HIV-1) reverse
transcriptase (RT) complexed with a 19-mer/18-mer double-stranded DNA
template-primer (dsDNA) and the Fab fragment of monoclonal antibody 28 (Fab28)
has been refined at 2.8 A resolution. The structures of the polymerase active
site and neighboring regions are described in detail and a number of novel
insights into mechanisms of polymerase catalysis and drug inhibition are
presented. The three catalytically essential amino acid residues (Asp110,
Asp185, and Asp186) are located close to the 3' terminus of the primer strand.
Observation of a hydrogen bond between the 3'-OH of the primer terminus and the
side-chain of Asp185 suggests that the carboxylate of Asp185 could act as a
general base in initiating the nucleophilic attack during polymerization. Nearly
all of the close protein-DNA interactions involve atoms of the sugar-phosphate
backbone of the nucleic acid. However, the phenoxyl side-chain of Tyr183, which
is part of the conserved YMDD motif, has hydrogen-bonding interactions with
nucleotide bases of the second duplex base-pair and is predicted to have at
least one hydrogen bond with all Watson-Crick base-pairs at this position.
Comparison of the structure of the active site region in the HIV-1 RT/dsDNA
complex with all other HIV-1 RT structures suggests that template-primer binding
is accompanied by significant conformational changes of the YMDD motif that may
be relevant for mechanisms of both polymerization and inhibition by
non-nucleoside inhibitors. Interactions of the "primer grip" (the
beta12-beta13 hairpin) with the 3' terminus of the primer strand primarily
involve the main-chain atoms of Met230 and Gly231 and the primer terminal
phosphate. Alternative positions of the primer grip observed in different HIV-1
RT structures may be related to conformational changes that normally occur
during DNA polymerization and translocation. In the vicinity of the polymerase
active site, there are a number of aromatic residues that are involved in
energetically favorable pi-pi interactions and may be involved in the
transitions between different stages of the catalytic process. The protein
structural elements primarily responsible for precise positioning of the
template-primer (including the primer grip, template grip, and helices alphaH
and alphaI of the p66 thumb) can be thought of functioning as a
"translocation track" that guides the relative movement of nucleic
acid and protein during polymerization.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Ribbon [Carson 1987] diagram showing the overall
structure of the HIV-1 RT/dsDNA/Fab28 complex. The subdomains of
the p66 and p51 subunits of HIV-1 RT are colored as follows:
fingers, blue; palm, red; thumb, green; connection, yellow; and
RNase H, orange. The bound dsDNA is shown with the template
strand as a dark gray ribbon and the primer strand as a light
gray ribbon; base-pairs are represented by bars. The monoclonal
antibody fragment Fab28 is shown with the light chain in light
gray and the heavy chain in dark gray.
|
 |
Figure 3.
Figure 3. (a) Structure of the polymerase active site region
of HIV-1 RT including the primer grip. Secondary structural
elements of the p66 palm subdomain are shown as red ribbons. The
three catalytically essential aspartic acid residues (Asp110,
Asp185, and Asp186) are shown with cyan side-chains. Tyr183 and
Met184, which form part of the conserved YMDD motif, are shown
with gold side-chains. Amino acid residues at the primer grip
are shown in green. The dsDNA is shown with the template strand
in dark gray and the primer strand in light gray. (b) A
schematic diagram showing interactions between the 3′-terminal
nucleotide of the primer strand (Pri1) and amino acid residues
at the polymerase active site, with selected distances given in
Å. Hydrogen-bonding interactions between the side-chain
O^δ1 atom of Asp185 and the 3′-OH of Pri1, and between the
amide nitrogen atom of Met230 of the primer grip and the
phosphate oxygen atom of Pri1 are indicated by heavy lines.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1998,
284,
1095-1111)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Lapkouski,
L.Tian,
J.T.Miller,
S.F.Le Grice,
and
W.Yang
(2013).
Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation.
|
| |
Nat Struct Mol Biol,
20,
230-236.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Mason,
A.Schuller,
and
E.Skordalakes
(2011).
Telomerase structure function.
|
| |
Curr Opin Struct Biol,
21,
92.
|
 |
|
|
|
|
 |
A.K.Upadhyay,
T.T.Talele,
and
V.N.Pandey
(2010).
Impact of template overhang-binding region of HIV-1 RT on the binding and orientation of the duplex region of the template-primer.
|
| |
Mol Cell Biochem,
338,
19-33.
|
 |
|
|
|
|
 |
G.L.Butterfoss,
E.F.DeRose,
S.A.Gabel,
L.Perera,
J.M.Krahn,
G.A.Mueller,
X.Zheng,
and
R.E.London
(2010).
Conformational dependence of 13C shielding and coupling constants for methionine methyl groups.
|
| |
J Biomol NMR,
48,
31-47.
|
 |
|
|
|
|
 |
J.Wang,
R.A.Bambara,
L.M.Demeter,
and
C.Dykes
(2010).
Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions.
|
| |
J Virol,
84,
9377-9389.
|
 |
|
|
|
|
 |
K.A.Delviks-Frankenberry,
G.N.Nikolenko,
and
V.K.Pathak
(2010).
The "Connection" Between HIV Drug Resistance and RNase H.
|
| |
Viruses,
2,
1476-1503.
|
 |
|
|
|
|
 |
K.Singh,
B.Marchand,
K.A.Kirby,
E.Michailidis,
and
S.G.Sarafianos
(2010).
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.
|
| |
Viruses,
2,
606-638.
|
 |
|
|
|
|
 |
M.Götte,
J.W.Rausch,
B.Marchand,
S.Sarafianos,
and
S.F.Le Grice
(2010).
Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.
|
| |
Biochim Biophys Acta,
1804,
1202-1212.
|
 |
|
|
|
|
 |
M.Mitchell,
A.Gillis,
M.Futahashi,
H.Fujiwara,
and
E.Skordalakes
(2010).
Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA.
|
| |
Nat Struct Mol Biol,
17,
513-518.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.W.Kellinger,
and
K.A.Johnson
(2010).
Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase.
|
| |
Proc Natl Acad Sci U S A,
107,
7734-7739.
|
 |
|
|
|
|
 |
P.R.Daga,
J.Duan,
and
R.J.Doerksen
(2010).
Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations.
|
| |
Protein Sci,
19,
796-807.
|
 |
|
|
|
|
 |
S.J.Schultz,
M.Zhang,
and
J.J.Champoux
(2010).
Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.
|
| |
J Mol Biol,
397,
161-178.
|
 |
|
|
|
|
 |
S.Kim,
C.M.Schroeder,
and
X.S.Xie
(2010).
Single-molecule study of DNA polymerization activity of HIV-1 reverse transcriptase on DNA templates.
|
| |
J Mol Biol,
395,
995.
|
 |
|
|
|
|
 |
A.Ivetac,
and
J.A.McCammon
(2009).
Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations.
|
| |
J Mol Biol,
388,
644-658.
|
 |
|
|
|
|
 |
C.Garriga,
M.J.Pérez-Elías,
R.Delgado,
L.Ruiz,
L.Pérez-Alvarez,
T.Pumarola,
A.López-Lirola,
J.González-García,
and
L.Menéndez-Arias
(2009).
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations.
|
| |
J Antimicrob Chemother,
64,
251-258.
|
 |
|
|
|
|
 |
K.Yasukawa,
M.Mizuno,
and
K.Inouye
(2009).
Characterization of Moloney murine leukaemia virus/avian myeloblastosis virus chimeric reverse transcriptases.
|
| |
J Biochem,
145,
315-324.
|
 |
|
|
|
|
 |
M.Mougel,
L.Houzet,
and
J.L.Darlix
(2009).
When is it time for reverse transcription to start and go?
|
| |
Retrovirology,
6,
24.
|
 |
|
|
|
|
 |
S.G.Sarafianos,
B.Marchand,
K.Das,
D.M.Himmel,
M.A.Parniak,
S.H.Hughes,
and
E.Arnold
(2009).
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition.
|
| |
J Mol Biol,
385,
693-713.
|
 |
|
|
|
|
 |
S.J.Schultz,
M.Zhang,
and
J.J.Champoux
(2009).
Preferred sequences within a defined cleavage window specify DNA 3' end-directed cleavages by retroviral RNases H.
|
| |
J Biol Chem,
284,
32225-32238.
|
 |
|
|
|
|
 |
T.A.Wilkinson,
K.Januszyk,
M.L.Phillips,
S.S.Tekeste,
M.Zhang,
J.T.Miller,
S.F.Le Grice,
R.T.Clubb,
and
S.A.Chow
(2009).
Identifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase.
|
| |
J Biol Chem,
284,
7931-7939.
|
 |
|
|
|
|
 |
T.Matamoros,
M.Nevot,
M.A.Martínez,
and
L.Menéndez-Arias
(2009).
Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.
|
| |
J Biol Chem,
284,
32792-32802.
|
 |
|
|
|
|
 |
Y.S.Lee,
W.D.Kennedy,
and
Y.W.Yin
(2009).
Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations.
|
| |
Cell,
139,
312-324.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.J.Gillis,
A.P.Schuller,
and
E.Skordalakes
(2008).
Structure of the Tribolium castaneum telomerase catalytic subunit TERT.
|
| |
Nature,
455,
633-637.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.A.Abbondanzieri,
G.Bokinsky,
J.W.Rausch,
J.X.Zhang,
S.F.Le Grice,
and
X.Zhuang
(2008).
Dynamic binding orientations direct activity of HIV reverse transcriptase.
|
| |
Nature,
453,
184-189.
|
 |
|
|
|
|
 |
E.P.Tchesnokov,
A.Obikhod,
R.F.Schinazi,
and
M.Götte
(2008).
Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase.
|
| |
J Biol Chem,
283,
34218-34228.
|
 |
|
|
|
|
 |
J.Lemay,
P.Maidou-Peindara,
T.Bader,
E.Ennifar,
J.C.Rain,
R.Benarous,
and
L.X.Liu
(2008).
HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells.
|
| |
Retrovirology,
5,
47.
|
 |
|
|
|
|
 |
J.Mendieta,
C.E.Cases-González,
T.Matamoros,
G.Ramírez,
and
L.Menéndez-Arias
(2008).
A Mg2+-induced conformational switch rendering a competent DNA polymerase catalytic complex.
|
| |
Proteins,
71,
565-574.
|
 |
|
|
|
|
 |
J.Oh,
M.J.McWilliams,
J.G.Julias,
and
S.H.Hughes
(2008).
Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.
|
| |
J Virol,
82,
719-727.
|
 |
|
|
|
|
 |
M.Ehteshami,
G.L.Beilhartz,
B.J.Scarth,
E.P.Tchesnokov,
S.McCormick,
B.Wynhoven,
P.R.Harrigan,
and
M.Götte
(2008).
Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.
|
| |
J Biol Chem,
283,
22222-22232.
|
 |
|
|
|
|
 |
M.L.Coté,
and
M.J.Roth
(2008).
Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.
|
| |
Virus Res,
134,
186-202.
|
 |
|
|
|
|
 |
S.J.Schultz,
and
J.J.Champoux
(2008).
RNase H activity: structure, specificity, and function in reverse transcription.
|
| |
Virus Res,
134,
86.
|
 |
|
|
|
|
 |
V.K.Jamburuthugoda,
J.M.Santos-Velazquez,
M.Skasko,
D.J.Operario,
V.Purohit,
P.Chugh,
E.A.Szymanski,
J.E.Wedekind,
R.A.Bambara,
and
B.Kim
(2008).
Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage.
|
| |
J Biol Chem,
283,
9206-9216.
|
 |
|
|
|
|
 |
V.Tereshko,
S.Uysal,
A.Koide,
K.Margalef,
S.Koide,
and
A.A.Kossiakoff
(2008).
Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold.
|
| |
Protein Sci,
17,
1175-1187.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.Rutvisuttinunt,
P.R.Meyer,
and
W.A.Scott
(2008).
Interactions between HIV-1 reverse transcriptase and the downstream template strand in stable complexes with primer-template.
|
| |
PLoS ONE,
3,
e3561.
|
 |
|
|
|
|
 |
B.Marchand,
E.P.Tchesnokov,
and
M.Götte
(2007).
The pyrophosphate analogue foscarnet traps the pre-translocational state of HIV-1 reverse transcriptase in a Brownian ratchet model of polymerase translocation.
|
| |
J Biol Chem,
282,
3337-3346.
|
 |
|
|
|
|
 |
C.Ferrer-Orta,
A.Arias,
R.Pérez-Luque,
C.Escarmís,
E.Domingo,
and
N.Verdaguer
(2007).
Sequential structures provide insights into the fidelity of RNA replication.
|
| |
Proc Natl Acad Sci U S A,
104,
9463-9468.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.M.Held,
J.D.Kissel,
S.J.Thacker,
D.Michalowski,
D.Saran,
J.Ji,
R.W.Hardy,
J.J.Rossi,
and
D.H.Burke
(2007).
Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
|
| |
J Virol,
81,
5375-5384.
|
 |
|
|
|
|
 |
D.Sengupta,
D.Verma,
and
P.K.Naik
(2007).
Docking mode of delvardine and its analogues into the p66 domain of HIV-1 reverse transcriptase: screening using molecular mechanics-generalized born/surface area and absorption, distribution, metabolism and excretion properties.
|
| |
J Biosci,
32,
1307-1316.
|
 |
|
|
|
|
 |
I.Olivares,
A.Mulky,
P.I.Boross,
J.Tözsér,
J.C.Kappes,
C.López-Galíndez,
and
L.Menéndez-Arias
(2007).
HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
|
| |
J Mol Biol,
372,
369-381.
|
 |
|
|
|
|
 |
K.A.Delviks-Frankenberry,
G.N.Nikolenko,
R.Barr,
and
V.K.Pathak
(2007).
Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance.
|
| |
J Virol,
81,
6837-6845.
|
 |
|
|
|
|
 |
P.R.Meyer,
W.Rutvisuttinunt,
S.E.Matsuura,
A.G.So,
and
W.A.Scott
(2007).
Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet.
|
| |
J Mol Biol,
369,
41-54.
|
 |
|
|
|
|
 |
Q.Xia,
J.Radzio,
K.S.Anderson,
and
N.Sluis-Cremer
(2007).
Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.
|
| |
Protein Sci,
16,
1728-1737.
|
 |
|
|
|
|
 |
W.C.Drosopoulos,
and
V.R.Prasad
(2007).
The active site residue Valine 867 in human telomerase reverse transcriptase influences nucleotide incorporation and fidelity.
|
| |
Nucleic Acids Res,
35,
1155-1168.
|
 |
|
|
|
|
 |
C.Dash,
J.P.Marino,
and
S.F.Le Grice
(2006).
Examining Ty3 polypurine tract structure and function by nucleoside analog interference.
|
| |
J Biol Chem,
281,
2773-2783.
|
 |
|
|
|
|
 |
C.Dash,
T.S.Fisher,
V.R.Prasad,
and
S.F.Le Grice
(2006).
Examining interactions of HIV-1 reverse transcriptase with single-stranded template nucleotides by nucleoside analog interference.
|
| |
J Biol Chem,
281,
27873-27881.
|
 |
|
|
|
|
 |
D.M.Himmel,
S.G.Sarafianos,
S.Dharmasena,
M.M.Hossain,
K.McCoy-Simandle,
T.Ilina,
A.D.Clark,
J.L.Knight,
J.G.Julias,
P.K.Clark,
K.Krogh-Jespersen,
R.M.Levy,
S.H.Hughes,
M.A.Parniak,
and
E.Arnold
(2006).
HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site.
|
| |
ACS Chem Biol,
1,
702-712.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Ruan,
K.Chen,
J.A.Tuszynski,
and
L.A.Kurgan
(2006).
Quantitative analysis of the conservation of the tertiary structure of protein segments.
|
| |
Protein J,
25,
301-315.
|
 |
|
|
|
|
 |
J.W.Noah,
S.Park,
J.T.Whitt,
J.Perutka,
W.Frey,
and
A.M.Lambowitz
(2006).
Atomic force microscopy reveals DNA bending during group II intron ribonucleoprotein particle integration into double-stranded DNA.
|
| |
Biochemistry,
45,
12424-12435.
|
 |
|
|
|
|
 |
N.Sluis-Cremer,
and
E.S.Kempner
(2006).
Radiation target analyses of DNA template/primer complexes.
|
| |
Biophys J,
90,
L61-L63.
|
 |
|
|
|
|
 |
O.Yokosuka,
and
M.Arai
(2006).
Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.
|
| |
Med Mol Morphol,
39,
113-120.
|
 |
|
|
|
|
 |
P.Neumann,
A.Koblízková,
A.Navrátilová,
and
J.Macas
(2006).
Significant expansion of Vicia pannonica genome size mediated by amplification of a single type of giant retroelement.
|
| |
Genetics,
173,
1047-1056.
|
 |
|
|
|
|
 |
R.A.Smith,
D.J.Anderson,
and
B.D.Preston
(2006).
Hypersusceptibility to substrate analogs conferred by mutations in human immunodeficiency virus type 1 reverse transcriptase.
|
| |
J Virol,
80,
7169-7178.
|
 |
|
|
|
|
 |
V.Goldschmidt,
J.Didierjean,
B.Ehresmann,
C.Ehresmann,
C.Isel,
and
R.Marquet
(2006).
Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance.
|
| |
Nucleic Acids Res,
34,
42-52.
|
 |
|
|
|
|
 |
A.Bibillo,
D.Lener,
A.Tewari,
and
S.F.Le Grice
(2005).
Interaction of the Ty3 reverse transcriptase thumb subdomain with template-primer.
|
| |
J Biol Chem,
280,
30282-30290.
|
 |
|
|
|
|
 |
A.Láng,
I.G.Csizmadia,
and
A.Perczel
(2005).
Peptide models XLV: conformational properties of N-formyl-L-methioninamide and its relevance to methionine in proteins.
|
| |
Proteins,
58,
571-588.
|
 |
|
|
|
|
 |
F.J.Blocker,
G.Mohr,
L.H.Conlan,
L.Qi,
M.Belfort,
and
A.M.Lambowitz
(2005).
Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase.
|
| |
RNA,
11,
14-28.
|
 |
|
|
|
|
 |
J.Didierjean,
C.Isel,
F.Querré,
J.F.Mouscadet,
A.M.Aubertin,
J.Y.Valnot,
S.R.Piettre,
and
R.Marquet
(2005).
Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
|
| |
Antimicrob Agents Chemother,
49,
4884-4894.
|
 |
|
|
|
|
 |
A.A.Thompson,
and
O.B.Peersen
(2004).
Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase.
|
| |
EMBO J,
23,
3462-3471.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.E.Cases-González,
and
L.Menéndez-Arias
(2004).
Increased G-->A transition frequencies displayed by primer grip mutants of human immunodeficiency virus type 1 reverse transcriptase.
|
| |
J Virol,
78,
1012-1019.
|
 |
|
|
|
|
 |
D.Das,
and
M.M.Georgiadis
(2004).
The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus.
|
| |
Structure,
12,
819-829.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.N.Peletskaya,
A.A.Kogon,
S.Tuske,
E.Arnold,
and
S.H.Hughes
(2004).
Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
|
| |
J Virol,
78,
3387-3397.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Lu,
J.Macosko,
D.Habel-Rodriguez,
R.W.Keller,
J.A.Brozik,
and
D.J.Keller
(2004).
Closing of the fingers domain generates motor forces in the HIV reverse transcriptase.
|
| |
J Biol Chem,
279,
54529-54532.
|
 |
|
|
|
|
 |
J.D.Pata,
W.G.Stirtan,
S.W.Goldstein,
and
T.A.Steitz
(2004).
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.
|
| |
Proc Natl Acad Sci U S A,
101,
10548-10553.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Winshell,
B.A.Paulson,
B.D.Buelow,
and
J.J.Champoux
(2004).
Requirements for DNA unpairing during displacement synthesis by HIV-1 reverse transcriptase.
|
| |
J Biol Chem,
279,
52924-52933.
|
 |
|
|
|
|
 |
L.Yang,
W.A.Beard,
S.H.Wilson,
S.Broyde,
and
T.Schlick
(2004).
Highly organized but pliant active site of DNA polymerase beta: compensatory mechanisms in mutant enzymes revealed by dynamics simulations and energy analyses.
|
| |
Biophys J,
86,
3392-3408.
|
 |
|
|
|
|
 |
N.Sluis-Cremer,
N.A.Temiz,
and
I.Bahar
(2004).
Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.
|
| |
Curr HIV Res,
2,
323-332.
|
 |
|
|
|
|
 |
P.R.Meyer,
A.J.Smith,
S.E.Matsuura,
and
W.A.Scott
(2004).
Effects of primer-template sequence on ATP-dependent removal of chain-terminating nucleotide analogues by HIV-1 reverse transcriptase.
|
| |
J Biol Chem,
279,
45389-45398.
|
 |
|
|
|
|
 |
R.L.Crowther,
D.P.Remeta,
C.A.Minetti,
D.Das,
S.P.Montano,
and
M.M.Georgiadis
(2004).
Structural and energetic characterization of nucleic acid-binding to the fingers domain of Moloney murine leukemia virus reverse transcriptase.
|
| |
Proteins,
57,
15-26.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Tuske,
S.G.Sarafianos,
A.D.Clark,
J.Ding,
L.K.Naeger,
K.L.White,
M.D.Miller,
C.S.Gibbs,
P.L.Boyer,
P.Clark,
G.Wang,
B.L.Gaffney,
R.A.Jones,
D.M.Jerina,
S.H.Hughes,
and
E.Arnold
(2004).
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir.
|
| |
Nat Struct Mol Biol,
11,
469-474.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Matamoros,
S.Franco,
B.M.Vázquez-Alvarez,
A.Mas,
M.A.Martínez,
and
L.Menéndez-Arias
(2004).
Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers.
|
| |
J Biol Chem,
279,
24569-24577.
|
 |
|
|
|
|
 |
B.Marchand,
and
M.Götte
(2003).
Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase. Implications for polymerase translocation and drug resistance.
|
| |
J Biol Chem,
278,
35362-35372.
|
 |
|
|
|
|
 |
B.Sharma,
N.Kaushik,
A.Upadhyay,
S.Tripathi,
K.Singh,
and
V.N.Pandey
(2003).
A positively charged side chain at position 154 on the beta8-alphaE loop of HIV-1 RT is required for stable ternary complex formation.
|
| |
Nucleic Acids Res,
31,
5167-5174.
|
 |
|
|
|
|
 |
K.Post,
J.Guo,
K.J.Howard,
M.D.Powell,
J.T.Miller,
A.Hizi,
S.F.Le Grice,
and
J.G.Levin
(2003).
Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription.
|
| |
J Virol,
77,
7623-7634.
|
 |
|
|
|
|
 |
L.Shen,
J.Shen,
X.Luo,
F.Cheng,
Y.Xu,
K.Chen,
E.Arnold,
J.Ding,
and
H.Jiang
(2003).
Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.
|
| |
Biophys J,
84,
3547-3563.
|
 |
|
|
|
|
 |
M.A.Wainberg
(2003).
HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors.
|
| |
J Acquir Immune Defic Syndr,
34,
S2-S7.
|
 |
|
|
|
|
 |
P.R.Meyer,
S.E.Matsuura,
D.Zonarich,
R.R.Chopra,
E.Pendarvis,
H.Z.Bazmi,
J.W.Mellors,
and
W.A.Scott
(2003).
Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.
|
| |
J Virol,
77,
6127-6137.
|
 |
|
|
|
|
 |
S.G.Sarafianos,
A.D.Clark,
S.Tuske,
C.J.Squire,
K.Das,
D.Sheng,
P.Ilankumaran,
A.R.Ramesha,
H.Kroth,
J.M.Sayer,
D.M.Jerina,
P.L.Boyer,
S.H.Hughes,
and
E.Arnold
(2003).
Trapping HIV-1 reverse transcriptase before and after translocation on DNA.
|
| |
J Biol Chem,
278,
16280-16288.
|
 |
|
|
|
|
 |
X.Xu,
Y.Liu,
S.Weiss,
E.Arnold,
S.G.Sarafianos,
and
J.Ding
(2003).
Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
|
| |
Nucleic Acids Res,
31,
7117-7130.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Iwatani,
A.E.Rosen,
J.Guo,
K.Musier-Forsyth,
and
J.G.Levin
(2003).
Efficient initiation of HIV-1 reverse transcription in vitro. Requirement for RNA sequences downstream of the primer binding site abrogated by nucleocapsid protein-dependent primer-template interactions.
|
| |
J Biol Chem,
278,
14185-14195.
|
 |
|
|
|
|
 |
Z.Sevilya,
S.Loya,
N.Adir,
and
A.Hizi
(2003).
The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
|
| |
Nucleic Acids Res,
31,
1481-1487.
|
 |
|
|
|
|
 |
J.D.Pata,
B.R.King,
and
T.A.Steitz
(2002).
Assembly, purification and crystallization of an active HIV-1 reverse transcriptase initiation complex.
|
| |
Nucleic Acids Res,
30,
4855-4863.
|
 |
|
|
|
|
 |
J.G.Julias,
M.J.McWilliams,
S.G.Sarafianos,
E.Arnold,
and
S.H.Hughes
(2002).
Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.
|
| |
Proc Natl Acad Sci U S A,
99,
9515-9520.
|
 |
|
|
|
|
 |
S.G.Sarafianos,
A.D.Clark,
K.Das,
S.Tuske,
J.J.Birktoft,
P.Ilankumaran,
A.R.Ramesha,
J.M.Sayer,
D.M.Jerina,
P.L.Boyer,
S.H.Hughes,
and
E.Arnold
(2002).
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA.
|
| |
EMBO J,
21,
6614-6624.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.S.Fisher,
P.Joshi,
and
V.R.Prasad
(2002).
Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication.
|
| |
J Virol,
76,
4068-4072.
|
 |
|
|
|
|
 |
A.Muroya,
D.Tsuchiya,
M.Ishikawa,
M.Haruki,
M.Morikawa,
S.Kanaya,
and
K.Morikawa
(2001).
Catalytic center of an archaeal type 2 ribonuclease H as revealed by X-ray crystallographic and mutational analyses.
|
| |
Protein Sci,
10,
707-714.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.N.Peletskaya,
P.L.Boyer,
A.A.Kogon,
P.Clark,
H.Kroth,
J.M.Sayer,
D.M.Jerina,
and
S.H.Hughes
(2001).
Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer.
|
| |
J Virol,
75,
9435-9445.
|
 |
|
|
|
|
 |
H.Q.Gao,
S.G.Sarafianos,
E.Arnold,
and
S.H.Hughes
(2001).
RNase H cleavage of the 5' end of the human immunodeficiency virus type 1 genome.
|
| |
J Virol,
75,
11874-11880.
|
 |
|
|
|
|
 |
K.Das,
X.Xiong,
H.Yang,
C.E.Westland,
C.S.Gibbs,
S.G.Sarafianos,
and
E.Arnold
(2001).
Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
|
| |
J Virol,
75,
4771-4779.
|
 |
|
|
|
|
 |
M.D.Driscoll,
M.P.Golinelli,
and
S.H.Hughes
(2001).
In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
|
| |
J Virol,
75,
672-686.
|
 |
|
|
|
|
 |
M.Gutiérrez-Rivas,
and
L.Menéndez-Arias
(2001).
A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis.
|
| |
Nucleic Acids Res,
29,
4963-4972.
|
 |
|
|
|
|
 |
M.Y.Tolstorukov,
V.I.Ivanov,
G.G.Malenkov,
R.L.Jernigan,
and
V.B.Zhurkin
(2001).
Sequence-dependent B<-->A transition in DNA evaluated with dimeric and trimeric scales.
|
| |
Biophys J,
81,
3409-3421.
|
 |
|
|
|
|
 |
P.L.Boyer,
S.G.Sarafianos,
E.Arnold,
and
S.H.Hughes
(2001).
Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
|
| |
J Virol,
75,
4832-4842.
|
 |
|
|
|
|
 |
S.G.Sarafianos,
K.Das,
C.Tantillo,
A.D.Clark,
J.Ding,
J.M.Whitcomb,
P.L.Boyer,
S.H.Hughes,
and
E.Arnold
(2001).
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.
|
| |
EMBO J,
20,
1449-1461.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Lin,
Z.H.Yuan,
L.Wu,
J.P.Ding,
and
Y.M.Wen
(2001).
A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.
|
| |
J Virol,
75,
11827-11833.
|
 |
|
|
|
|
 |
G.J.Klarmann,
R.A.Smith,
R.F.Schinazi,
T.W.North,
and
B.D.Preston
(2000).
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site.
|
| |
J Biol Chem,
275,
359-366.
|
 |
|
|
|
|
 |
P.L.Boyer,
S.G.Sarafianos,
E.Arnold,
and
S.H.Hughes
(2000).
Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.
|
| |
Proc Natl Acad Sci U S A,
97,
3056-3061.
|
 |
|
|
|
|
 |
P.L.Boyer,
and
S.H.Hughes
(2000).
Effects of amino acid substitutions at position 115 on the fidelity of human immunodeficiency virus type 1 reverse transcriptase.
|
| |
J Virol,
74,
6494-6500.
|
 |
|
|
|
|
 |
I.Olivares,
V.Sánchez-Merino,
M.A.Martínez,
E.Domingo,
C.López-Galíndez,
and
L.Menéndez-Arias
(1999).
Second-site reversion of a human immunodeficiency virus type 1 reverse transcriptase mutant that restores enzyme function and replication capacity.
|
| |
J Virol,
73,
6293-6298.
|
 |
|
|
|
|
 |
M.D.Powell,
W.A.Beard,
K.Bebenek,
K.J.Howard,
S.F.Le Grice,
T.A.Darden,
T.A.Kunkel,
S.H.Wilson,
and
J.G.Levin
(1999).
Residues in the alphaH and alphaI helices of the HIV-1 reverse transcriptase thumb subdomain required for the specificity of RNase H-catalyzed removal of the polypurine tract primer.
|
| |
J Biol Chem,
274,
19885-19893.
|
 |
|
|
|
|
 |
M.Madrid,
A.Jacobo-Molina,
J.Ding,
and
E.Arnold
(1999).
Major subdomain rearrangement in HIV-1 reverse transcriptase simulated by molecular dynamics.
|
| |
Proteins,
35,
332-337.
|
 |
|
|
|
|
 |
S.G.Sarafianos,
K.Das,
A.D.Clark,
J.Ding,
P.L.Boyer,
S.H.Hughes,
and
E.Arnold
(1999).
Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids.
|
| |
Proc Natl Acad Sci U S A,
96,
10027-10032.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.G.Sarafianos,
K.Das,
J.Ding,
P.L.Boyer,
S.H.Hughes,
and
E.Arnold
(1999).
Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site.
|
| |
Chem Biol,
6,
R137-R146.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| |